BioChange Ltd.

📍 Yokneam, Israel🗓 Founded 2017👥 11 employees💰 Last funded Nov 2021
Biotechnology Research🌐 biochange.life
Website LinkedIn
BioChange has developed a breakthrough technology for tissue regeneration. A unique injectable scaffold that stimulates tissue repair and remodelling at the injected site. The scaffold is based on natural biomaterials designed for implantation using a minimally invasive procedure. It mimics the healthy Extra Cellular Matrix (ECM) and triggers the body to repair itself. Multiple long-term animal studies confirmed the safety and efficacy of the technology. The company is now selling products in the veterinary market and in tissue engineering research and is committed to start first clinical study in aesthetic dermatology in late 2023. Next in pipeline product is intended to treat the most prevalent degenerative disease of gum retraction (periodontitis).
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in BioChange Ltd.?
BioChange Ltd. has 1 investors on record on gritt.io, 1 mid-stage.
When did BioChange Ltd. last raise funding?
The most recent investment in BioChange Ltd. recorded on gritt.io was in November 2021.
When was BioChange Ltd. founded?
BioChange Ltd. was founded in 2017.
What industry is BioChange Ltd. in?
BioChange Ltd. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioChange Ltd. based?
BioChange Ltd. is headquartered in Yokneam, Israel.